NB Renaissance Partners and Chequers Capital announced that they have signed an agreement with Wise Sgr to jointly acquire a controlling stake of the Biolchim Group, leader in the production and marketing of special fertilizers. The group’s management, led by Leonardo Valenti, will retain a stake share of about 8%.
From 2008 to date Biochim has completed four strategic acquisitions, including Cifo S.r.l. and 60% of Ilsa S.p.A. with the purpose of expanding the product portfolio, increasing the production capacity and enhancing the research and development.
Over the last few years the Group has grown significantly, passing from a revenue of 30 million in 2008 to an expected 115 million in 2017.
Today the international market represents about 35% of the turnover and is expected to grow more, also thanks to the strong synergy with Ilsa in the R&D sector.
Stefano Bontempelli and Marco De Simoni, NB Renaissance partners have commented:
Biolchim is an Italian entrepreneur excellence and an internationally recognized leader in the special fertilizer sector, a worldwide market driven by important long-term growth prospects. Thanks to a successful business model and constant commitment to research and innovation, today Biolchim represents a unique reality in its reference market and our goal is to support the management to further accelerate the Group growth at an international level.
Guillaume Planchon and Philippe Guérin, respectively partner and head of investment in Italy for Chequers Capital, also commented:
We are very happy to join the Biolchim Group and its management in their path of international development and constant innovation. We believe that in the next years Biolchim can strengthen its leadership in to the biostimulants market and we intend to make our experience and support available to the management to complete further acquisitions and realize their strategic plan.
Leonardo Valenti, president and CEO of the Biolchim Group, expressed his satisfaction and said:
After the important results obtained thanks to the support of Wise, the ambitions of the Group and the management remain unchanged and we believe that NB Renaissance and Chequers, world leading private equity funds with a high international profile, represent the ideal partners for supporting the Biolchim Group in its forthcoming growth phase by enhancing its development and consolidation, especially in the international markets. Our commitment as managers and shareholders is confirmed and represents the best guarantee for the future of the Group, which aims to be increasingly present in the world of biostimulants and to reach new and prestigious goals.
Michele Semenzato and Luigi Vagnozzi, responsible for the investments in Wise, have declared:
Biolchim represented for Wise a model operation: we invested in an Italian excellence in a context of a growing market, with a management team that has been outstanding in every way and we have accompanied it in a growth pathway both organic and for external lines, in order to create one of the world leading players in the biostimulants market. We are convinced that the growth and consolidation process that has taken place over the years will be able to continue with success also with the new shareholders.